Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-05-22T16:51:07.619Z Has data issue: false hasContentIssue false

7 - Radiolabelled Compounds

Published online by Cambridge University Press:  26 October 2011

Chandrani Liyanage
Affiliation:
Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
Manjula Hettiarachchi
Affiliation:
Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
Get access

Summary

PREPARATION AND ASSESSMENT OF RADIOLABELLED COMPOUNDS USED AS TRACERS IN RIA

In a radioimmunoassay system, the response variable relies entirely on the measurement of the radiolabelied tracer in the bound or free fraction of the analyte, after separation. The kinetics of the reaction is entirely followed using the tracer without actually estimating the amount of analyte. Hence, it is imperative to understand the methods of preparation and purification of tracers, concept of purity, qualities of tracers used in RIAs and assessment of their qualities.

A radiolabelied molecule has a radionuclide in its structure, which disintegrates that molecule from others due to the emission of radiation that can be measured. In general, two types of radiolabelled compounds are encountered:

  1. a. Genuinely-labelled compounds

  2. b. Foreign-labelled compounds.

In genuinely-labelled compounds, one of the constituent atoms is replaced by a radioactive nuclide of the same element in the same position. Most compounds of clinical interest are biochemicals having C, H, N, O, P, and S as their constituents and it would be appropriate to choose a corresponding radionuclide of these elements for labelling by substitution. For example,14C or 3H in methanol and l25I in thyroxine, tri-iodothyronine etc.

Introduction of a foreign label should be done in such a way that labelled entity retains the ability to react with the antibodies. In foreign-labelled compounds, the element whose radionuclide is used for labelling is not an original constituent of the molecule. Either the radionuclide replaces an original non-reactive atom of another element or is part of large group appended to analyte molecule.

Type
Chapter
Information
Radionuclides in Biomedical Sciences
An Introduction
, pp. 85 - 88
Publisher: Foundation Books
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Radiolabelled Compounds
  • Chandrani Liyanage, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka, Manjula Hettiarachchi, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
  • Book: Radionuclides in Biomedical Sciences
  • Online publication: 26 October 2011
  • Chapter DOI: https://doi.org/10.1017/UPO9788175968158.009
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Radiolabelled Compounds
  • Chandrani Liyanage, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka, Manjula Hettiarachchi, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
  • Book: Radionuclides in Biomedical Sciences
  • Online publication: 26 October 2011
  • Chapter DOI: https://doi.org/10.1017/UPO9788175968158.009
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Radiolabelled Compounds
  • Chandrani Liyanage, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka, Manjula Hettiarachchi, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
  • Book: Radionuclides in Biomedical Sciences
  • Online publication: 26 October 2011
  • Chapter DOI: https://doi.org/10.1017/UPO9788175968158.009
Available formats
×